U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
113701113701Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid ArthritisTerminatedNo Results AvailableArthritis, RheumatoidDrug: Otelixizumab|Drug: Matching placebohttps://ClinicalTrials.gov/show/NCT01077531
113702113702Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing RegimenRecruitingNo Results AvailableLymphoma, FollicularDrug: Ofatumumab and Bendamustine infusions (Arm A)|Drug: Bendamustine infusion (Arm B)https://ClinicalTrials.gov/show/NCT01077518
113703113703An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .CompletedNo Results AvailableHealthy Female Volunteers|Diabetes Mellitus, Type 2Biological: albiglutide|Drug: Oral contraceptive (Brevicon)https://ClinicalTrials.gov/show/NCT01077505
113704113704Virtual Bronchoscopy Transbronchial Needle Aspiration(TBNA): a Proof of Concept StudyTerminatedNo Results AvailableLung CancerOther: Virtual Bronchoscopy Navigationhttps://ClinicalTrials.gov/show/NCT01077492
113705113705Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic SyndromeCompletedNo Results AvailableMetabolic Syndrome|HypercholesterolemiaDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01077479
113706113706Natalizumab Treatment of Progressive Multiple SclerosisCompletedNo Results AvailablePrimary Progressive Multiple Sclerosis|Secondary Progressive Multiple SclerosisDrug: Natalizumabhttps://ClinicalTrials.gov/show/NCT01077466
113707113707Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast CancerCompletedNo Results AvailableHealthy, no Evidence of Disease|Lobular Breast Carcinoma in SituDrug: letrozole|Other: quality-of-life assessment|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01077453
113708113708Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantTerminatedNo Results AvailableCancer Survivor|Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Neuroblastoma|Testicular Germ Cell TumorGenetic: DNA analysis|Genetic: polymerase chain reaction|Other: flow cytometry|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01077440
113709113709Hyperthermia European Adjuvant TrialRecruitingNo Results AvailableResected Pancreatic AdenocarcinomaDevice: Gemcitabine + Cisplatin + regional hyperthermia|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT01077427
113710113710Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening IllnessCompletedNo Results AvailableCancer|Painhttps://ClinicalTrials.gov/show/NCT01077414
113711113711Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 StudyRecruitingNo Results AvailableDiabetic Macular EdemaDrug: Ranibizumab|Drug: ranibizumabhttps://ClinicalTrials.gov/show/NCT01077401
113712113712e-Care for Heart WellnessCompletedNo Results AvailableCVDBehavioral: Dietician electronic supporthttps://ClinicalTrials.gov/show/NCT01077388
113713113713Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of FibromyalgiaCompletedHas ResultsFibromyalgiaDrug: Placebo|Drug: Milnacipranhttps://ClinicalTrials.gov/show/NCT01077375
113714113714A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF AgentsCompletedHas ResultsArthritis, PsoriaticDrug: placebo|Drug: ustekinumab 45 mg|Drug: ustekinumab 90 mghttps://ClinicalTrials.gov/show/NCT01077362
113715113715High Volume Veno-venous Hemofiltration Versus Standard Care for Post-cardiac Surgery ShockCompletedNo Results AvailableShockProcedure: high volume hemofiltration|Procedure: standard carehttps://ClinicalTrials.gov/show/NCT01077349
113716113716Clinical Outcomes in Candidemia Patients Based on in Vitro SusceptibilityCompletedNo Results AvailableBlood Stream Infections|Candidahttps://ClinicalTrials.gov/show/NCT01077336
113717113717A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic AgentsCompletedHas ResultsType 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies)|Healthy Subjects (Treated With no Diabetes Therapies)Drug: exenatide|Drug: Other antidiabetic therapies|Other: No diabetes therapyhttps://ClinicalTrials.gov/show/NCT01077323
113718113718Alcohol Pharmacotherapy for HIV+ PrisonersActive, not recruitingNo Results AvailableAlcohol Dependence|Problem Drinking|Hazardous Drinking|Human Immunodeficiency Virus|AIDSDrug: Vivitrol- Intramuscular naltrexone (depot-formulation)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01077310
113719113719Tezosentan in Pulmonary Arterial HypertensionTerminatedNo Results AvailablePulmonary Arterial HypertensionDrug: Tezosentanhttps://ClinicalTrials.gov/show/NCT01077297
113720113720Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate StonesCompletedHas ResultsHyperuricosuria|Kidney StonesDrug: Febuxostat|Drug: Allopurinol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01077284
113721113721Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGACompletedHas ResultsPremature Infantshttps://ClinicalTrials.gov/show/NCT01077271
113722113722Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeCompletedHas ResultsRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01077258
113723113723Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile InfectionsWithdrawnNo Results AvailableClostridium Difficile InfectionDrug: MIYA-BM Fine Granules (CBM588)|Drug: Placebo Fine Granules (without CBM588)https://ClinicalTrials.gov/show/NCT01077245
113724113724Documentation of Humira in Psoriasis Patients in Routine Clinical PracticeRecruitingNo Results AvailableModerate to Severe Plaque Psoriasishttps://ClinicalTrials.gov/show/NCT01077232
113725113725Study on Energy Cost Prediction of Cycle ErgometerCompletedNo Results AvailableHealthy|Obesityhttps://ClinicalTrials.gov/show/NCT01077219
113726113726High-dose Simvastatin for Aneurysmal Subarachnoid HaemorrhageCompletedNo Results AvailableSubarachnoid HemorrhageDrug: Simvastatinhttps://ClinicalTrials.gov/show/NCT01077206
113727113727Surgical Intervention in Bariatric Patients: Excess Weight Loss in the Morbidly Obese Following Gastric PlicationTerminatedHas ResultsMorbid ObesityProcedure: Gastric Plicationhttps://ClinicalTrials.gov/show/NCT01077193
113728113728Rheos Feasibility TrialCompletedNo Results AvailableHypertensionDevice: Implantation of the Rheos Systemhttps://ClinicalTrials.gov/show/NCT01077180
113729113729Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure PatientsWithdrawnNo Results AvailableHeart FailureDrug: Omecamtiv mecarbilhttps://ClinicalTrials.gov/show/NCT01077167
113730113730Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)Active, not recruitingNo Results AvailableBreast CancerDrug: Placebo|Drug: Denosumabhttps://ClinicalTrials.gov/show/NCT01077154

* Görseller ve İçerik tekif hakkına sahip olabilir